Treatments for prostate cancer include radiation therapy, hormone therapy and surgery. These procedures
are also known as androgen ablation therapy because it lowers intensity and quantity of the male hormones
that can rouse the growth certain types of prostate cancer.
Reducing the intensity of hormone levels makes prostate cancer grow or shrink very slowly. Medical
professionals consider it the most efficient systemic therapy for prostate cancer. However, over time,
nearly all prostate cancers become immune or resistant to this treatment.
The new approach for prostate cancer treatment is on the anvil. It is based on new discoveries regarding
how prostate cancer cells become able to fight hormone treatment. According to specialists from Wake Forest
University School of Medicine and their colleagues, the new findings will lead to more effective drug treatments
Focusing to the way prostate cancer cells become resistant to androgen ablation therapy, the research team
found that BAD protein is very much involved in three different survival strategies developed by the cancer cells.
By studying the BAD action, medical team hope to discover the mechanism the cancer become resistant to the
treatment and cancel it.
NOTE: The Information on this site is provided for information only, and is not meant to substitute for
the advice of your own physician or other medical professional.